Home
Random
Nearby
Log in
Settings
Donate
About Wikidata
Disclaimers
Search
(Q33869361)
Watch
English
Clinical status of duplex RNA
scientific article
In more languages
edit
Statements
instance of
scholarly article
1 reference
stated in
Europe PubMed Central
PubMed ID
20399650
retrieved
29 July 2017
title
Clinical status of duplex RNA
(English)
1 reference
stated in
Europe PubMed Central
PubMed ID
20399650
retrieved
29 July 2017
author name string
Jonathan K Watts
series ordinal
1
1 reference
stated in
Europe PubMed Central
PubMed ID
20399650
retrieved
29 July 2017
David R Corey
series ordinal
2
1 reference
stated in
Europe PubMed Central
PubMed ID
20399650
retrieved
29 July 2017
language of work or name
English
0 references
publication date
2 April 2010
1 reference
stated in
Europe PubMed Central
PubMed ID
20399650
retrieved
29 July 2017
published in
Bioorganic & Medicinal Chemistry Letters
1 reference
stated in
Europe PubMed Central
PubMed ID
20399650
retrieved
29 July 2017
volume
20
1 reference
stated in
Europe PubMed Central
PubMed ID
20399650
retrieved
29 July 2017
issue
11
1 reference
stated in
Europe PubMed Central
PubMed ID
20399650
retrieved
29 July 2017
page(s)
3203-3207
1 reference
stated in
Europe PubMed Central
PubMed ID
20399650
retrieved
29 July 2017
cites work
Evidence of RNAi in humans from systemically administered siRNA via targeted nanoparticles
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2874620
retrieved
5 July 2018
RNAi-based therapeutics-current status, challenges and prospects
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2874620
retrieved
5 July 2018
Recognizing and avoiding siRNA off-target effects for target identification and therapeutic application
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2874620
retrieved
5 July 2018
First-in-human mutation-targeted siRNA phase Ib trial of an inherited skin disorder.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2874620
retrieved
5 July 2018
Sequence-non-specific effects of RNA interference triggers and microRNA regulators
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2874620
retrieved
5 July 2018
RNA interference-mediated silencing of the respiratory syncytial virus nucleocapsid defines a potent antiviral strategy
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2874620
retrieved
5 July 2018
siRNA and innate immunity
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2874620
retrieved
5 July 2018
Confirming the RNAi-mediated mechanism of action of siRNA-based cancer therapeutics in mice
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2874620
retrieved
5 July 2018
The promises and pitfalls of RNA-interference-based therapeutics
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2874620
retrieved
5 July 2018
A three-dimensional view of the molecular machinery of RNA interference
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2874620
retrieved
5 July 2018
On the road to reading the RNA-interference code
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2874620
retrieved
5 July 2018
RNA interference: from basic research to therapeutic applications
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2874620
retrieved
5 July 2018
Chemically modified siRNA: tools and applications.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2874620
retrieved
5 July 2018
Sequence- and target-independent angiogenesis suppression by siRNA via TLR3
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2874620
retrieved
5 July 2018
Overcoming the innate immune response to small interfering RNA.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2874620
retrieved
5 July 2018
Chemical modification: the key to clinical application of RNA interference?
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2874620
retrieved
5 July 2018
Interfering with disease: a progress report on siRNA-based therapeutics
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2874620
retrieved
5 July 2018
Administration in non-human primates of escalating intravenous doses of targeted nanoparticles containing ribonucleotide reductase subunit M2 siRNA.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2874620
retrieved
5 July 2018
A novel siRNA-lipoplex technology for RNA interference in the mouse vascular endothelium
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2874620
retrieved
5 July 2018
Identification of a novel hypoxia-inducible factor 1-responsive gene, RTP801, involved in apoptosis.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2874620
retrieved
5 July 2018
Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2874620
retrieved
5 July 2018
A chemical inhibitor of p53 that protects mice from the side effects of cancer therapy
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2874620
retrieved
5 July 2018
Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2874620
retrieved
5 July 2018
Atu027, a liposomal small interfering RNA formulation targeting protein kinase N3, inhibits cancer progression.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2874620
retrieved
29 October 2018
Evaluation of the safety, tolerability and pharmacokinetics of ALN-RSV01, a novel RNAi antiviral therapeutic directed against respiratory syncytial virus (RSV).
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2874620
retrieved
29 October 2018
Therapeutic silencing of an endogenous gene by systemic administration of modified siRNAs
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2874620
retrieved
29 October 2018
Biodistribution of phosphodiester and phosphorothioate siRNA.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2874620
retrieved
29 October 2018
Wet age-related macular degeneration
1 reference
stated in
PubMed
reference URL
https://pubmed.ncbi.nlm.nih.gov/20399650
retrieved
12 December 2020
based on heuristic
inferred from PubMed ID database lookup
Identifiers
DOI
10.1016/J.BMCL.2010.03.109
1 reference
stated in
Europe PubMed Central
PubMed ID
20399650
retrieved
29 July 2017
PMCID
2874620
1 reference
stated in
Europe PubMed Central
PubMed ID
20399650
retrieved
29 July 2017
PubMed ID
20399650
1 reference
stated in
Europe PubMed Central
PubMed ID
20399650
retrieved
29 July 2017
ResearchGate publication ID
43182231
0 references
Sitelinks
Wikipedia
(0 entries)
edit
Wikibooks
(0 entries)
edit
Wikinews
(0 entries)
edit
Wikiquote
(0 entries)
edit
Wikisource
(0 entries)
edit
Wikiversity
(0 entries)
edit
Wikivoyage
(0 entries)
edit
Wiktionary
(0 entries)
edit
Multilingual sites
(0 entries)
edit
